Biosyent Inc (BIOYF) 5.7675 $BIOYF BioSyent Releases Q1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosyent Inc (BIOYF) 5.7675 $BIOYF

BioSyent Releases Q1 2016 Results
Marketwire Canada - Fri May 27, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - May 27, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) released today a summary of its financial results for the three months ending March 31, 2016. Key highlights include:
RX.VN: 7.680 (unch)

FeraMAX(R) Named #1 by Canadian Doctors and Pharmacists
Marketwire Canada - Thu May 26, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - May 26, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) is pleased to announce that its FeraMAX® brand was recently named as the #1 recommended over-the-counter ("OTC" iron supplement brand in a national survey of Canadian physicians and pharmacists.
RX.VN: 7.680 (unch)

IIROC Trade Resumption - BioSyent Inc.
Newsfile Corp - Wed May 25, 12:00PM CDT
Trading resumes in:

BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products
Marketwire Canada - Wed May 25, 11:54AM CDT
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma International Inc. has signed an exclusive Distribution Agreement with a European partner for two new products in the cardiovascular therapeutic area for the Canadian market. The products have been approved in Europe and in certain other markets around the world and will be launched in Canada if approval is granted by Health Canada. BioSyent intends to submit the dossier seeking marketing approval of the products to Health Canada in 2016.
RX.VN: 7.680 (unch)

IIROC Trade Halt - BioSyent Inc.
Newsfile Corp - Wed May 25, 11:48AM CDT
The following issues have been halted by IIROC:

BioSyent Schedules Q1 2016 Earnings Release for May 27, 2016
Marketwire Canada - Wed May 25, 9:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) will be reporting its financial results for the three months ending March 31, 2016 on Friday, May 27, 2016 at 8:00am (EST). A presentation on the Company's first quarter 2016 results by Mr. René Goehrum, BioSyent President and CEO, will also be available on the Company's website on the date of release.
RX.VN: 7.680 (unch)

BioSyent Pharma Receives Health Canada Approval for New Urgent Care Product Using the Aguettant System(R)
Marketwired - Thu May 05, 7:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 5, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received approval from Health Canada for a new urgent care product, phenylephrine hydrochloride injection in the Aguettant System® pre-filled syringe (PFS), for use in hospitals and acute care settings.
RX.VN: 7.680 (unch)

BioSyent to Present at Upcoming Investor Conferences
Marketwired - Wed Apr 06, 1:08PM CDT
BioSyent Inc. ("BioSyent"(TSX VENTURE: RX)(OTC PINK: BIOYF) is pleased to announce that it will be presenting at the following upcoming investor conferences:
RX.VN: 7.680 (unch)

BioSyent Releases Q4 and Full Year 2015 Results
Marketwired - Fri Mar 04, 7:01AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX)(OTC PINK: BIOYF) released today a summary of its financial results for the three and twelve months ending December 31, 2015. Key highlights include:
RX.VN: 7.680 (unch)

BioSyent to Present at the LD Micro Main Event 2015 Investor Conference
Marketwired - Mon Nov 30, 8:57AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that CEO Rene Goehrum will be making a presentation at the LD Micro Main Event 2015 Investor Conference at 9am (PT) on December 3, 2015 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Goehrum will provide an overview of the Company and its corporate activities.
RX.VN: 7.680 (unch)

BioSyent Pharma Announces the Canadian Launch of CYSVIEW(R) (Hexaminolevulinate Hydrochloride)
Marketwired - Tue Nov 17, 7:04AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of CYSVIEW(R), a new photosensitizer for the detection and management of papillary Non-Muscle Invasive Bladder Cancer (NMIBC).
RX.VN: 7.680 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 4

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 7

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join Sensorion's Upcoming Webconference for Retail Investors

Updated Category News Views 49

Unlocking Hearing Health: Sensorion's Webconference for Retail Investors Sensorion, a trailblazer in the clinical-stage biotech space, is making waves in hearing loss therapy. They’ve announced a dedicated webconference that’s exclusively for retail shareholders—yeah, those everyday investors looking to get the lowdown on where their money's going. The Lowdown on...

Continue Reading
Mantle Network Revolutionizes Crypto with ZK Validity Rollup

Updated Category News Views 93

Transforming the Crypto Landscape with ZK Rollups Mantle Network is making significant strides in the realm of blockchain technology by advancing its technical roadmap. Recently, the network established a pioneering alliance with Succinct, positioning it as the highest total value locked (TVL) ZK validity rollup within the Ethereum layer 2 ecosystem. This transition marks...

Continue Reading
Columbus Implements Share Buyback Program for Investor Value

Updated Category News Views 146

Overview of Columbus A/S Share Buyback Program Columbus A/S is actively engaging in a share buyback initiative to support its investors and enhance the overall value of the company. Announced earlier, the program permits the corporation to repurchase shares worth up to DKK 16 million from June to March the following year. Details of Recent Transactions Timeframe of...

Continue Reading
Prospect Capital Plans Fiscal Earnings Call Ahead

Updated Category News Views 87

Prospect Capital Announces Earnings Call for Fiscal Year Prospect Capital Corporation (NASDAQ: PSEC) has revealed plans for an upcoming earnings release and conference call regarding its fiscal year that ended on June 30, 2024. This report will be submitted to the Securities and Exchange Commission, providing a detailed overview of the company's financial performance....

Continue Reading
10x Genomics Unveils Affordable Solutions for Single Cell Analysis

Updated Category News Views 90

Innovations in Single Cell Analysis by 10x Genomics At the recent Human Cell Atlas General Meeting, 10x Genomics, Inc. (NASDAQ: TXG) unveiled groundbreaking plans that promise to revolutionize single cell analysis. This exciting announcement is a significant step towards making advanced single cell technology accessible to researchers across the globe. Affordable...

Continue Reading